Open Outcrier Sign Up/Sign In
Sign Up/Sign In

Open Outcrier is a news and chat platform geared toward options traders.


What's Inside

Open Outcrier Feed

Tons of trades and insights that are not posted to other socials.

The Pit

Real-time chat with other traders and the Open Outcrier folks themselves.

Full Search

Search through news articles, posts, and chat.

Custom Benzinga Feed

More in-depth than the free one on their site.

Daily Digest

Pre-market news sent straight to your inbox.

Sign Up Today

Free 2-week trial, no credit card required

Free Email Digest

$0/mo

  • Daily digest, delivered via email

Pro Platform Access

$99/mo

2 week free trial, no credit card required. One month free when you subscribe yearly.
  • Full access to the platform
  • Open Outcrier Feed
  • Real-time Chat
  • Custom Benzinga News Feed
  • Daily Email Digest
Try for Free

Compare Plans

Free Email Digest Pro Platform Access
Daily Email Digest Optional
Access to Open Outcrier Platform
Open Outcrier Feed
Real-time Chat with Other Traders
Custom Benzinga News Feed
Platform-spanning Cashtag Search
Try for Free

What We're Watching Today

Econ Calendar Mon 6/8/26Treasury Buyback Announcement (Preliminary) 11:00 AM ET3-Month Bill Auction 6-Month Bill Auction 11:30 AM ET
Nasdaq futures gain as chip stocks rebound from Friday’s rout, Trump tries to maintain ceasefire - CNBC
Trump Tells Israel and Iran to Stop Exchanges of Fire - WSJ
Trump insists negotiations are continuing despite Israel and Iran trading strikes - CNBC
Both sides, Israel and Iran, are looking to do an immediate CEASEFIRE! Final negotiations on “Peace” are proceeding, subject to ignorance or stupidity getting in its way. The Blockade will remain in place, and in full force and effect, until a “Final Deal” is reached. Things should move quickly. Thank you for your attention to this matter! President DONALD J. TRUMP
Trump and Netanyahu’s Rift Over Lebanon Is Deepening - WSJ
Houthis to Impose ‘Complete Ban’ on Israeli Ships in Red Sea - BBG
US Stocks Halt Rout Even as Rising Oil Lifts Rates - BBG
Trump faces new Republican resistance in Congress as midterm pressures build - Reuters
House Republican Says Hegseth’s D-Day Remarks ‘Inappropriate’ - BBG
Trump storms out of interview after being challenged about election fraud claims, DOJ fund - CNBC
US Supreme Court poised to rule on gun laws and transgender athletes - Reuters
Epstein abused them. The Justice Department exposed them. Now they’re under attack by haters - Reuters
The Hidden Figure With Close Ties to Bill Gates and Jeffrey Epstein - WSJ
Goldman Sachs pushes Fed rate-cut call to 2027 on strong US jobs data
European leaders ready to support ceasefire talks between Ukraine, Russia
IMF Chief Warns World Isn’t Ready for Shocks That Are Piling Up - BBG
Bank of England's Taylor sees rates on hold barring worst-case scenario - Reuters
The European Union Has a $2 Trillion Taiwan Problem - BBG
China’s Xi to visit North Korea for first time in seven years as Beijing tests its influence over Kim - CNBC
Xi Gets Warm North Korea Welcome as Kim Draws Nuclear Red Line - BBG
China's global e-commerce push stalls as Iran war lifts costs, dampens demand - Reuters
China says 'illegal' outbound investment crackdown won't lead to forced liquidation - Reuters
Foreign investors have dumped billions of dollars of Korean stocks this year despite record rally. Here’s why - CNBC
South Korea's KOSPI craters over 8% as Fed fears spark tech rout -Reuters
Iranian Crude Offered to China at Discount as Demand Softens - BBG
OPEC, Allies Pledge Oil-Output Hike Even as Middle East War Chokes Exports - WSJ
Oil prices pull back from highs after Trump says Israel and Iran want a ceasefire - CNBC
Gold hits more than two-month low as strong US jobs data boosts rate-hike bets
Bitcoin teetering on brink of further losses
Sterling muscled toward two-month lows by robust dollar - Reuters
$WIX (-10.4% pre) WIX reduces workforce by 20% amid strategic realignment - SI
$MRVL (+9.3% pre) Marvell Technology jumps almost 9% in premarket after news it will join the S&P 500 index- CNBC
$IPFX (+7.9% pre) Quantum Space to go public via SPAC deal with Inflection Point - SA
OpenAI plans ChatGPT 'superapp' overhaul ahead of listing, FT reports
$NCRA (+75.0% pre) NASDAQ-listed Nocera enters AI venture agreement with Digital Innovations Group
Intesa Bids $35 Billion for Monte dei Paschi - WSJ
$SPCX How SpaceX Became Embedded in America’s War Machine - WSJ
$SPCX Gwynne Shotwell, the 'glue' executing Musk's lofty SpaceX ambitions - Reuters
$SPCX What the ‘Dean of Valuation’ Thinks Elon Musk’s SpaceX Is Really Worth - WSJ
$NVDA (+2.1% pre) Nvidia Takes the Top Spot in the 2026 List of Best Companies for the Future - WSJ
$NVDA (+2.1% pre) Nvidia clinches deals with South Korean giants including SK Group to advance AI boom
$NVDA (+2.1% pre) Samsung Elec's chip chief says he discussed next-generation foundry with Nvidia CEO
$NVDA (+2.1% pre) Nvidia's AI PC push banks on unproven demand beyond niche users
$AAPL (+0.4% pre) Inside Apple’s Secret Meeting That Led It to Finally Take AI Seriously - BBG
$AAPL (+0.4% pre) Apple Investors Look for AI Overhaul to Power Next Leg of Gains - BBG
$ACON (-4.5% pre) Aclarion rejects Echo Lake Capital's $4 per share acquisition offer - SI
@mingchikuo $AAPL WWDC26 won't change Apple's positive 2H26 share-price trend, but it will test the staying power of the bull narrative ‒‒ 1. Apple's core bull narrative right now is an almost intuitive market consensus that few people push back on: "Even if Apple is temporarily behind on AI, it will ultimately catch up and come out ahead."2. Based on my latest supply-chain checks, I believe Apple's business momentum will remain strong through year-end, which should further reinforce the narrative into something like: "If Apple is doing this well without AI, just imagine once it has AI."3. So regardless of what Apple says at WWDC26, as long as this core bull narrative stays intact, Apple's positive 2H26 share-price trend is unlikely to change.
@mingchikuo $AAPL4. That core bull narrative has its weak spots, but I think it has a good chance of holding at least through end-2026. How much longer it can last is what makes WWDC26 genuinely worth watching.5. The key takeaway from WWDC26 will not be the short-term share-price reaction after the event. It will be whether Apple, using the same Gemini, can deliver better AI applications, agentic workflows, and on-device & cloud hybrid experiences than Google.6. If the answer is yes, it would help extend Apple's core bull narrative. If the answer is no, it would suggest that Gemini sets the ceiling for Apple's AI experience. The stock may not necessarily turn bearish, but the "Apple will ultimately come out ahead" narrative would start to face growing scrutiny.
$ABAT (+28.0% pre) FinancialContent - American Battery Technology Company Wins Appeal and Has US Department of Energy Grant Reinstated for $115 million Project for Commercial Scale Critical Mineral Lithium Refinery
$HAWK (+6.0% pre) HawkEye 360 Announces Over $100 Million in New International Contract Awards
$SUNE (+156.6% pre) SUNation Energy and Suniva Enter Definitive Merger Agreement, Creating a Platform for American Solar Manufacturing and Services Leadership
$ELAB (+11.0% pre) NorthStrive Defense Tech Executes Binding Agreement to Acquire Exclusive License to Patented Multi-Domain Drone Payload Technology for Defense, Aerospace and Maritime Applications
$GOCO (-37.3% pre) GoHealth files for Chapter 11 bankruptcy with stakeholder support
$LXEH (-15.4% pre) Lixiang Education Regains Compliance with Nasdaq Minimum Market Value of Publicly Held Shares Requirement
$STI (+3.0% pre) Solidion Technology receives 7 new US patents for battery anode materials
$FLEX (+4.3% pre) Flex Ltd. (FLEX.US) join the S&P 500 Index
$ARTV (+7.3% pre) Artiva receives FDA RMAT designation for rheumatoid arthritis therapy
$CGEM (+8.1% pre) Cullinan Therapeutics reports positive CLN-978 data at EULAR 2026 - SI
$ELDN (+10.0% pre) Eledon reports insulin independence in all 12 type 1 diabetes patients
$NRIX (+12.7% pre) Nurix Therapeutics partners with Roche on BTK degrader drug deal
$LLY (+1.7% pre) Eli Lilly stock surged after its next-generation weight loss drug posted record results
$LYEL (-17.2% pre) Lyell amends colorectal cancer trial after reducing side effects - SI
$STTK (+16.6% pre) Shattuck Labs reports positive Phase 1 results for DR3 blocking antibody
$TNGX (+45.2% pre) Tango drug combination shows 92% response rate in pancreatic cancer trial
$TNXP (+5.7% pre) Tonix Pharmaceuticals expands TONMYA coverage to 52 million lives
$GLW (+9.2% pre) $AMZN Amazon signs multibillion-dollar fiber deal with Corning
$ALOT (+8.2% pre) Margin gains lift AstroNova (NASDAQ: ALOT) to Q1 FY27 profit
$CPB (+2.3% pre) Campbell's Q3 2026 earnings: sales fall 4%, guidance reaffirmed
$FCEL (+5.0% pre) FuelCell Energy: Fiscal Q2 Earnings Snapshot
$GMHS (+59.6% pre) Mobile game maker Gamehaus trims ads, lifts profit in Q3
$HON (+0.8% pre) Honeywell lifts annual profit forecast ahead of aerospace spinoff
$MPAA (+32.1% pre) Motorcar Parts of America (Nasdaq: MPAA) returns to profit and lifts 2027 EBITDA outlook
$OCC (+69.9% pre) Fiber cable maker OCC swings to profit as data center demand climbs
$GHM (-7.6% pre) Graham: Fiscal Q4 Earnings Snapshot
$VFS (-4.0% pre) VFS: Revenue up 41.7% year-over-year, but net loss widened and gross margin declined sharply
Top Earnings Mon 6/8 Aft: $AVO $GLOO $MAMA $MTN $ZEPP
Top Earnings Tu 6/9 Pre: $ASO $DBI $EH $LE $SAIL $SJM $THCH $TITN $UEC $UNFI
$FRSX (+37.2% pre) Foresight receives $17.5M investment from $VWAV VisionWave at $34M valuation
$LQDA (+3.5% pre) Liquidia added to S&P SmallCap 600 index effective June 22
Upgrades 6/8: $BF/B $BIIB $CAR $CMI $CROX $CTSH $KRC $MGEE $NVRI $TFX $VOYA $WRB
Downgrades 6/8: $ADCT $ALL $BXSL $CSR $NGG $RYAN $WRB
+Initiations 6/8: $AVNT $BTSG $BXDC $CBRS $CBT $CLYM $DMRA $DVN $EMBJ $EROK $FRVO $GAME $GMRS $IBIO $IBKR $INVX $IXHL $KTB $KWR $LTRX $RITM $TRAX $TVRD $ZENA
$BJDX (-7.7% pre) Bluejay Diagnostics raises $8.5M to fund FDA work, runway expected into 2027
$STI (-2.0% pre) Solidion Technology raises $35 million in private placement above market
$VNRX (-13.4% pre) VolitionRx prices $4.6 million stock offering at $1.55 per share
$XOS (-14.8% pre) Form S-3 Xos, Inc.
Top Shareholder Meetings: $APO $ASAN $CRWV $MSTR $RDDT
Top Analyst/Investor Calls: $ARTV $ASAN $DLTH $HON $PEGA
Top Conferences: o Apple WWDC o Goldman Sachs Healthcare Conference o Kepler CEO/CFO Tour o Oppenheimer Consumer Growth & ECommerce Conference o Roth Capital AdTech Summit